NP Pharmacology & Prescribing Flashcards
6 cards from real NP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 NP Pharmacology & Prescribing flashcards as text
A nurse practitioner prescribes metformin for a patient with type 2 diabetes. Which condition is an absolute contraindication to metformin use?
Answer: eGFR < 30 mL/min/1.73m²
Metformin is contraindicated when eGFR falls below 30 mL/min/1.73m² due to the risk of lactic acidosis from drug accumulation.
When prescribing warfarin, which INR target range is appropriate for a patient with atrial fibrillation and no mechanical heart valve?
Answer: 2.0–3.0
For non-valvular atrial fibrillation, the target INR range is 2.0–3.0 to balance stroke prevention with bleeding risk.
A patient is started on lisinopril and develops a dry, persistent cough. What is the most appropriate next step?
Answer: Switch to an ARB such as losartan
ACE inhibitor–induced cough is a class effect caused by bradykinin accumulation; switching to an ARB eliminates this side effect.
Which schedule II controlled substance requires a new written or electronic prescription for each fill in most US states and cannot be called in by phone?
Answer: Oxycodone
Oxycodone is a Schedule II opioid; federal law prohibits oral prescriptions for Schedule II substances, requiring a written or electronic prescription for each supply.
An NP prescribes azithromycin for a patient already taking amiodarone. What is the primary safety concern?
Answer: Prolonged QT interval and risk of torsades de pointes
Both azithromycin and amiodarone independently prolong the QT interval; combining them significantly increases the risk of potentially fatal arrhythmias.
Which drug class is first-line therapy for newly diagnosed hypertension in a non-Black patient without compelling indications, per JNC guidelines?
Answer: Thiazide diuretics, ACE inhibitors, ARBs, or CCBs
Current guidelines recommend thiazide diuretics, ACE inhibitors, ARBs, or calcium channel blockers as first-line agents for most non-Black hypertensive patients.